Overall, the study included 107 children with an average age of 11 years, of which 55% were male and 82% were Caucasian. At baseline, all
children displayed a
normal height, weight, BMI, and body composition. During the treatment, the team observed that some patients showed a reduction of up to 0.5 per unit in height, weight, and BMI z scores (standard deviation scores), discovering that 33% of children in the 48-week treatment group had a reduction of ≥ 0.5 in their height-for-age z score.